Loading...
A review of omalizumab for the management of severe asthma
Despite the expansion of the understanding in asthma pathophysiology and the continual advances in disease management, a small subgroup of patients remain partially controlled or refractory to standard treatments. Upon the identification of immunoglobulin E and other inflammatory mediators, investig...
Na minha lista:
| Udgivet i: | Drug Des Devel Ther |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4970638/ https://ncbi.nlm.nih.gov/pubmed/27528798 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S112208 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|